MedTrace Logo

Study to Analyze the Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists

NCT06191055 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2024-05-17

No results posted yet for this study

Summary

Randomized, controlled, double-blind, single-center, controlled clinical trial with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product) to measure the efficacy of 28-day consumption of a sustained-release beta alanine on the physiological efficacy of physical performance in recreational cyclists.

Conditions

  • Beta Alanine Supplementation

Interventions

DIETARY_SUPPLEMENT

Beta Alanine high dose

4 intakes of 5 g of beta alanine every 3 hour.

DIETARY_SUPPLEMENT

Beta Alanine low dose

4 intakes of 2.5 g of beta alanine every 3 hour.

OTHER

Control group

4 intakes of 2.5 g of wheat semolina every 3 hour.

Sponsors & Collaborators

  • Universidad Católica San Antonio de Murcia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-04
Primary Completion
2024-02-05
Completion
2024-03-11

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06191055 on ClinicalTrials.gov